Control of acromegaly in more than 90% of patients after 10 years of pegvisomant therapy: an European referral centre real-life experience.
R PirchioR S AuriemmaM E MontiniA VerguraR PivonelloAnnamaria ColaoPublished in: Journal of endocrinological investigation (2023)
PEG is effective and safe in long term. In patients resistant to SRLs, early beginning of PEG allows a wider gluco-insulinemic improvement.